Stem cells: A new paradigm for disease modeling and developing therapies for age-related macular degeneration

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Melville, Heather ^a   Carpiniello, Matthew ^a   Hollis, Kia ^a   Staffaroni, Andrew ^a   Golestaneh, Nady ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; RPE; Stem cells

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANGIOGENESIS INHIBITOR; APOLIPOPROTEIN E; BEVACIZUMAB; CHOLESTEROL ESTER TRANSFER PROTEIN; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; GLUTATHIONE TRANSFERASE M1; LIVER TRIACYLGLYCEROL LIPASE; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYLACTIC ACID; RANIBIZUMAB; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE SCAFFOLD; VASCULOTROPIN A;

BIOCOMPATIBILITY; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUSEN; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; HEREDITY; HUMAN; LASER COAGULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATIENT SAFETY; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STARGARDT DISEASE; STEM CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

DISEASE PROGRESSION; EMBRYONIC STEM CELLS; HUMANS; MACULAR DEGENERATION; MODELS, THEORETICAL; PLURIPOTENT STEM CELLS; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84874397454     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-53     Document Type: Review

References (135)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age related macular degeneration: emerging pathogenetic and therapeutic concepts. Ann Med 2006, 38:450-471. 10.1080/07853890600946724, 17101537.
2. Rein DB, Wittenborn JS, Zhang X. Forecasting age-related macular degeneration through the year 2005. The potential impact of new treatments. Arch Ophthalmol 2009, 127:533-540. 10.1001/archophthalmol.2009.58, 19365036.
3. Nowak J. Age related macular degeneration: pathogenesis and therapy. Pharmacol Rep 2006, 58:353-363.
4. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in Age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999, 44:1-29. 10.1016/S0039-6257(99)00072-7, 10466585.
5. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984, 102:1640-1642. 10.1001/archopht.1984.01040031330019, 6208888.
6. Bull ND, Martin KR. Concise review: toward stem cell-based therapies for retinal neurodegenerative diseases. Stem Cells 2011, 29:1170-1175. 10.1002/stem.676, 21674700.
7. Sin HPY, Liu DTL, Lam DSC. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration. Acta Ophthalmol 2012, http://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2011.02357.x/abstract.
8. Couch SM, Bakri SJ. Review of combination therapies for neovascular Age-related macular degeneration. Semin Ophthalmol 2011, 26:114-120. 10.3109/08820538.2011.577130, 21609223.
9. Marchetti V, Krohne TU, Friedlander DF, Friedlander M. Stemming vision loss with stem cells. J Clin Invest 2010, 120:3012-3021. 10.1172/JCI42951, 2929728, 20811157.
10. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
11. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
12. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872. 10.1016/j.cell.2007.11.019, 18035408.
13. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV, Clegg DO. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009, 27:2427-2434. 10.1002/stem.189, 19658190.
14. Carr A, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL, Buchholz DE, Ahmado A, Semo M, Smart MJK, Hasan S, da Cruz L, Johnson LV, Clegg DO, Coffey PJ. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic Rat. PLoS One 2009, 4:e8152. 10.1371/journal.pone.0008152, 2780911, 19997644.
15. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, Yoshimura N, Takahashi M. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009, 458:126-131. 10.1016/j.neulet.2009.04.035, 19379795.
16. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135. 10.1002/stem.149, 19521979.
17. Liao J, Yu J, Huang K, Hu J, Diemer T, Ma Z, Dvash T, Yang X, Travis GH, Williams DS, Bok D, Fan G. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet 2010, 19:4229-4238. 10.1093/hmg/ddq341, 3115666, 20709808.
18. Kokkinaki M, Sahibzada N, Golestaneh N. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit Ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011, 29:825-835. 10.1002/stem.635, 3322554, 21480547.
19. Du H, Lim SL, Grob S, Zhang K. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration. Semin Ophthalmol 2011, 26:216-224. 10.3109/08820538.2011.577498, 21609235.
20. Bok D. The retinal pigmented epithelium: a versatile partner in vision. J Cell Sci 1993, 17:189-195.
21. Boulton M, Dayhaw-Barker P. The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye 2001, 15:384-389. 10.1038/eye.2001.141, 11450762.
22. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005, 85:845-881. 10.1152/physrev.00021.2004, 15987797.
23. Wimmers S, Karl MO, Strauss O. Ion channels in the RPE. Prog Retin Eye Res 2007, 26:263-301. 10.1016/j.preteyeres.2006.12.002, 17258931.
24. Cai J, Nelson KC, Wu M, Sternberg P, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000, 19:205-221. 10.1016/S1350-9462(99)00009-9, 10674708.
25. Negi AMM. EXperimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 1984, 102:445-449. 10.1001/archopht.1984.01040030359038, 6703994.
26. Feeney-Burns L, Gao CL, Tidwell M. Lysosomal enzyme cytochemistry of human RPE, Bruch's membrane and drusen. Invest Ophthalmol Vis Sci 1987, 28:1138-1147.
27. Farkas T, Sylvester V, Archer D, Altona M. The histochemistry of drusen. Am J Ophthalmol 1971, 71:1206-1215.
28. Farkas T, Sylvester V, Archer D. The ultrastructure of drusen. Am J Ophthalmol 1971, 71:1196-1205.
29. Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 2005, 115:2793-2800. 10.1172/JCI24635, 1201663, 16167083.
30. Buschini E, Piras A, Nuzzi R, Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 2011, 95:14-25. 10.1016/j.pneurobio.2011.05.011, 21740956.
31. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res 2011, 30:217-238. 10.1016/j.preteyeres.2011.02.004, 21440663.
32. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 1999, 13:477-484.
33. Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO. Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in Age-related macular degeneration. Exp Eye Res 2002, 74:141-154. 10.1006/exer.2001.1112, 11878827.
34. Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA. Abundant lipid and protein components of drusen. PLoS One 2010, 5:10329.
35. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000, 70:441-449. 10.1006/exer.1999.0798, 10865992.
36. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan S. Formation of drusen in the human eye. Am J Ophthalmol 1986, 101:342-353.
37. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002, 134:411-431. 10.1016/S0002-9394(02)01624-0, 12208254.
38. Hoh Kam J, Lenassi E, Jeffery G. Viewing ageing eyes: diverse sites of amyloid beta accumulation in the ageing mouse retina and the Up-regulation of macrophages. PLoS One 2010, 5:e13127. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0013127, 10.1371/journal.pone.0013127, 2948519, 20957206.
39. Leveziel N, Tilleul J, Puche N, Zerbib J, Laloum F, Querques G, Souied EH. Genetic factors associated with Age-related macular degeneration. Ophthalmologica 2011, 226:87-102. 10.1159/000328981, 21757876.
40. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci 2010, 107:7401-7406. 10.1073/pnas.0912702107, 2867722, 20385819, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group.
41. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of Age-related macular degeneration. Science 2005, 308:419-421. 10.1126/science.1110359, 15761120.
42. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006, 38:458-462. 10.1038/ng1750, 2921703, 16518403.
43. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006, 38:1173-1177. 10.1038/ng1890, 16998489.
44. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007, 39:1200-1201. 10.1038/ng2131, 17767156.
45. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007, 16:1986-1992. 10.1093/hmg/ddm146, 17576744.
46. Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT. Complement C3 variant and the risk of Age-related macular degeneration. N Engl J Med 2007, 357:553-561. 10.1056/NEJMoa072618, 17634448.
47. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB. C2 And CFB genes in Age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One 2008, 3:e2199. 10.1371/journal.pone.0002199, 2374901, 18493315.
48. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, Agarwal A, Postel EA, Pericak-Vance MA, Haines JL. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet 2008, 17:971-977.
49. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and Age-related macular degeneration. Science 2005, 308:421-424. 10.1126/science.1110189, 15761121.
50. DeWan A, Liu M, Hartman S, Zhang SS, Liu DTL, Zhao C, Tam POS, Chan WM, Lam DSC, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 Promoter polymorphism in Wet Age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807, 17053108.
51. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, DeWan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to Age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811, 17053109.
52. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci 1998, 39:1021-1027.
53. Baird PN, Guida E, Chu DT, Vu HTV, Guymer RH. The ε2 and ε4 alleles of the apolipoprotein gene Are associated with Age-related macular degeneration. Invest Ophthalmol Vis Sci 2004, 45:1311-1315. 10.1167/iovs.03-1121, 15111582.
54. Schmidt S, Haines J, Postel E, Agarwal A, Kwan S, Gilbert J, Pericak-Vance M, Scott W. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 2006, 11:941-949.
55. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, Olson L, Kenealy SJ, Hauser M, Gilbert JR, Pericak-Vance MA. Functional candidate genes in Age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006, 47:329-335. 10.1167/iovs.05-0116, 16384981.
56. SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, Reed GF, Henning AK, Sivakumaran TA, Xu X, DeWan A, AgrÃn E, Rochtchina E, Sue CM, Wang JJ, Mitchell P, Hoh J, Francis PJ, Klein ML, Chew EY, Chakravarti A. Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 Are associated with increased risk of Age-related macular degeneration. PLoS One 2009, 4:e5508. 10.1371/journal.pone.0005508, 2677106, 19434233.
57. Jones M, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, Sue CM. MItochondrial dna haplogroups and age-related maculopathy. Arch Ophthalmol 2007, 125:1235-1240. 10.1001/archopht.125.9.1235, 17846364.
58. Udar N, Atilano SR, Memarzadeh M, Boyer DS, Chwa M, Lu S, Maguen B, Langberg J, Coskun P, Wallace DC, Nesburn AB, Khatibi N, Hertzog D, Le K, Hwang D, Kenney MC. Mitochondrial DNA haplogroups associated with Age-related macular degeneration. Invest Ophthalmol Vis Sci 2009, 50:2966-2974. 10.1167/iovs.08-2646, 19151382.
59. Cideciyan AV, Aleman TS, Swider M, Schwartz SB, Steinberg JD, Brucker AJ, Maguire AM, Bennett J, Stone EM, Jacobson SG. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 2004, 13:525-534. 10.1093/hmg/ddh048, 14709597.
60. Fraga MF. Genetic and epigenetic regulation of aging. Curr Opin Immunol 2009, 21:446-453. 10.1016/j.coi.2009.04.003, 19500963.
61. Swaroop A, Chew EY, Bowes Rickman C, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for Age-related macular degeneration. Annu Rev Genom Human Genet 2009, 10:19-43.
62. Cvekl A, Mitton KP. Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity 2010, 105:135-151. 10.1038/hdy.2010.16, 20179734.
63. Seddon JM, Reynolds R, Shah HR, Rosner B. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications [abstract]. Ophthalmology 2011, 118:1386-1394.
64. Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen H, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris F, Chew E, McCoy J, Blum E, Francis P, Klein M, Guymer R, Baird P, Chan C, Nussenblatt R. Hypomethylation of the IL17RC promoter associates with Age-related macular degeneration [abstract]. Cell Reports 2012, 2:1151-1158. 10.1016/j.celrep.2012.10.013, 3513594, 23177625.
65. Hunter A, Spechler PA, Cwanger A, Song Y, Zhang Z, Ying G, Hunter AK, deZoeten E, Dunaief JL. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci 2012, 53:2089-2105. 10.1167/iovs.11-8449, 22410570.
66. Suuronen T, Nuutinen T, Ryhänen T, Kaarniranta K, Salminen A. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun 2007, 357:397-401. 10.1016/j.bbrc.2007.03.135, 17420006.
67. Hjelmeland LM. Dark matters in AMD genetics: epigenetics and stochasticity. Invest Ophthalmol Vis Sci 2011, 52:1622-1631. 10.1167/iovs.10-6765, 3101660, 21429863.
68. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). PNAS 2010, 107:7395-7400. 10.1073/pnas.0912019107, 2867697, 20385826.
69. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet 2012, 379:1728-1738. 10.1016/S0140-6736(12)60282-7, 22559899.
70. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N, Khaner H, Smith Y, Wiser O, Gropp M, Cohen MA, Even-Ram S, Berman-Zaken Y, Matzrafi L, Rechavi G, Banin E, Reubinoff B. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009, 5:396-408. 10.1016/j.stem.2009.07.002, 19796620.
71. Salero E, Blenkinsop T, Corneo B, Harris A, Rabin D, Stern J, Temple S. Adult human RPE Can Be activated into a multipotent stem cell that produces mesenchymal derivatives [abstract]. Cell Stem Cell 2012, 10:88-95. 10.1016/j.stem.2011.11.018, 22226358.
72. Velez-Montoya R, Oliver S, Olson J, Fine S, Mandava N, Quiroz-Mercado H. Current knowledge and trends in age-related macular degeneration: today's and future treatments. Retina 2012, http://www.ncbi.nlm.nih.gov/pubmed/23222393.
73. Bessho K, Rodanant N, Bartsch DG, Cheng L, Koh H, Freeman WR. Effect of subthreshold infrared laser treatment for drusen regression on macular autofluorescence in patients with Age-related macular degeneration. Retina 2005, 25:981-9. 10.1097/00006982-200512000-00005, 16340527.
74. Parodi M, Virgili G, Evans J. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev 2009, 3. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006537.pub2/abstract.
75. Kaiser RS, Berger JW, Maguire MG, Ho AC, Javornik NB, Choroidal Neovascularization Prevention Trial Study Group Laser burn intensity and the risk for choroidal neovascularization in the CNVPT fellow Eye study. Arch Ophthalmol 2001, 119:826-832. 10.1001/archopht.119.6.826, 11405833, Choroidal Neovascularization Prevention Trial Study Group.
76. Ferrara N. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med 2010, 16:1107-1111. 10.1038/nm1010-1107, 20930754.
77. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487. 10.1056/NEJM199412013312203, 7526212.
78. Veritti D, Sarao V, Lanzetta P. Neovascular Age-related macular degeneration. Ophthalmologica 2012, 227:11-20. 10.1159/000337154, 22517121.
79. Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular Age-related macular degeneration. Retina 2006, 26:859. 10.1097/01.iae.0000242842.14624.e7, 17031284.
80. Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A, Kono T, Ishibashi T. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and Re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci 2012, 53:4323-4328. 10.1167/iovs.11-9119, 22661475.
81. Martin D, Maguire MG, Ying G, Grunwald J, Fine S, Jaffe G. Ranibizumab and Bevacizumab for neovascular Age-related macular degeneration. N Engl J Med 2011, 364:1897-1908. 3157322, 21526923.
82. Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL. Ranibizumab and Bevacizumab for treatment of neovascular Age-related macular degeneration: Two-year results. Ophthalmology 2012, 119:1388-1398. 10.1016/j.ophtha.2012.03.053, 22555112.
83. Levine JP, Marcus I, Sorensen JA, Spaide RF, Cooney MJ, Freund B. Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy. Retina 2009, 29:1074-1079. 10.1097/IAE.0b013e3181b09443, 19734761.
84. Ohji M, Fujikado T, Kusaka S, Hayashi A, Hosohata J, Ikuno Y, Sawa M, Kubota A, Hashida N, Tano Y. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol 2001, 132:888-896. 10.1016/S0002-9394(01)01255-7, 11730654.
85. Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt K, Gelisken F. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol 2009, 247:745-754. 10.1007/s00417-009-1050-5, 19214552.
86. van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol 2003, 136:688-695. 10.1016/S0002-9394(03)00384-2, 14516809.
87. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, Swaroop A, Sowden JC, Ali RR. Retinal repair by transplantation of photoreceptor precursors. Nature 2006, 444:203-207. 10.1038/nature05161, 17093405.
88. MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PMG, Milliken AB, Ali RR, Rubin GS, Aylward GW, da Cruz L. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular Age-related macular degeneration. Ophthalmology 2007, 114:561-570.e2. 10.1016/j.ophtha.2006.06.049, 17324698.
89. Gouras P, Flood M, Kjeldbye H. Transplantation of cultured human retinal cells to monkey retina. An Acad Bras Cienc 1984, 56:431-434.
90. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res 2007, 26:516-554. 10.1016/j.preteyeres.2007.02.002, 17532250.
91. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P. RPE transplantation and its role in retinal disease. Prog Retin Eye Res 2007, 26:598-635. 10.1016/j.preteyeres.2007.07.001, 17920328.
92. Limb GA, Daniels JT. Ocular regeneration by stem cells: present status and future prospects. Br Med Bull 2008, 85:47-61. 10.1093/bmb/ldn008, 18292605.
93. Ohta K, Ito A, Tanaka H. Neuronal stem/progenitor cells in the vertebrate eye. Dev Growth Differ 2008, 50:253-259. 10.1111/j.1440-169X.2008.01006.x, 18336580.
94. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, Akaike A, Sasai Y, Takahashi M. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotech 2008, 26:215-224.
95. Binder S, Krebs I, Hilgers R, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H. Outcome of transplantation of autologous retinal pigment epithelium in Age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 2004, 45:4151-4160. 10.1167/iovs.04-0118, 15505069.
96. Binder S. Scaffolds for retinal pigment epithelium (RPE) replacement therapy. Br J Ophthalmol 2011, 95:441-442. 10.1136/bjo.2009.171926, 21415062.
97. Treharne AJ, Grossel MC, Lotery AJ, Thomson HA. The chemistry of retinal transplantation: the influence of polymer scaffold properties on retinal cell adhesion and control. Br J Ophthalmol 2011, 95:768-773. 10.1136/bjo.2010.184002, 20807710.
98. Del Priore LV, Tezel TH, Kaplan HJ. Maculoplasty for age-related macular degeneration: reengineering Bruch's membrane and the human macula. Prog Retin Eye Res 2006, 25:539-562. 10.1016/j.preteyeres.2006.08.001, 17071125.
99. Crafoord S, Algvere PV, Seregard S, Kopp ED. Long-term outcome of RPE allografts to the subretinal space of rabbits. Acta Ophthalmol 1999, 77:247-254.
100. Tamiya S, Liu L, Kaplan HJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci 2010, 51:2755-2763. 10.1167/iovs.09-4725, 20042656.
101. MacLaren RE, Pearson RA. Stem cell therapy and the retina. Eye 2007, 21:1352-1359. 10.1038/sj.eye.6702842, 17914439.
102. Djojosubroto M, Bollotte F, Wirapati P, Radtke F, Stamenkovic I, Arsenijevic Y. Chromosomal number aberrations and transformation in adult mouse retinal stem cells In vitro. Invest Ophthalmol Vis Sci 2009, 50:5975-5987. 10.1167/iovs.08-3091, 19628750.
103. MacNeil A, Pearson RA, MacLaren RE, Smith AJ, Sowden JC, Ali RR. Comparative analysis of progenitor cells isolated from the iris, pars plana, and ciliary body of the adult porcine Eye. Stem Cells 2007, 25:2430-2438. 10.1634/stemcells.2007-0035, 17600111.
104. West EL, Pearson RA, MacLaren RE, Sowden JC, Ali RR. Cell transplantation strategies for retinal repair. Prog Brain Res 2009, 175:3-21. 3272389, 19660645.
105. Tucker BA, Redenti SM, Jiang C, Swift JS, Klassen HJ, Smith ME, Wnek GE, Young MJ. The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation. Biomaterials 2010, 31:9-19. 10.1016/j.biomaterials.2009.09.015, 19775744.
106. Streilein JW, Ma N, Wenkel H, Fong Ng T, Zamiri P. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res 2002, 42:487-495. 10.1016/S0042-6989(01)00185-7, 11853765.
107. Sheridan C, Williams R, Grierson I. Basement membranes and artificial substrates in cell transplantation. Graefes Arch Clin Exp Ophthalmol 2004, 242:68-75. 10.1007/s00417-003-0800-z, 14628146.
108. Tezel TH, Del Priore LV, Kaplan HJ. Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci 2004, 45:3337-3348. 10.1167/iovs.04-0193, 15326159.
109. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA. Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res 2005, 80:235-248. 10.1016/j.exer.2004.09.006, 15670802.
110. Tomita M, Lavik E, Klassen H, Zahir T, Langer R, Young MJ. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells 2005, 23:1579-1588. 10.1634/stemcells.2005-0111, 16293582.
111. Atala A. Tissue engineering for bladder substitution. World J Urol 2000, 18:364-370. 10.1007/s003450000152, 11131316.
112. Shin K, Jayasuriya AC, Kohn DH. Effect of ionic activity products on the structure and composition of mineral self assembled on three-dimensional poly(lactide-co-glycolide) scaffolds. J Biomed Mater Res A 2007, 83:1076-1086. 2744813, 17584901.
113. Tao S, Young C, Redenti S, Zhang Y, Klassen H, Desai T, Young MJ. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip 2007, 7:695-701. 10.1039/b618583e, 17538710.
114. Neeley WL, Redenti S, Klassen H, Tao S, Desai T, Young MJ, Langer R. A microfabricated scaffold for retinal progenitor cell grafting. Biomaterials 2008, 29:418-426. 10.1016/j.biomaterials.2007.10.007, 2174396, 17961646.
115. Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H, Langer R, Young MJ. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials 2009, 30:3405-3414. 10.1016/j.biomaterials.2009.02.046, 19361860.
116. Ghosh F, Neeley WL, Arner K, Langer R. Selective removal of photoreceptor cells in vivo using the biodegradable elastomer poly(glycerol sebacate). Tissue Eng Part A 2011, 17:1675-1682. 10.1089/ten.tea.2008.0450, 3118651, 19191667.
117. Redenti S, Tao S, Yang J, Gu P, Klassen H, Saigal S, Desai T, Young MJ. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J Ocul Biol Dis Infor. 2008, 1:19-29. 10.1007/s12177-008-9005-3, 2802414, 20072632.
118. Lund R, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauvé Y, Lanza R. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006, 8:189-199. 10.1089/clo.2006.8.189, 17009895.
119. Meyer JS, Katz ML, Maruniak JA, Kirk MD. Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells 2006, 24:274-283. 10.1634/stemcells.2005-0059, 3381839, 16123383.
120. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A, Lundh P, Semo M, Ahmado A, Gias C, da Cruz L, Moore H, Andrews P, Walsh J, Coffey P. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 2008, 214:347-361. 10.1016/j.expneurol.2008.09.007, 18926821.
121. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protocols 2009, 4:811-824.
122. Klimanskaya I, Hipp J, Rezai K, West M, Atala A, Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Stem Cells and Cloning 2004, 6:217-245.
123. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci 1995, 36:955-964.
124. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70. 10.1016/j.stem.2007.05.014, 18371336.
125. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE. Induced pluripotent stem cells and embryonic stem cells Are distinguished by gene expression signatures [abstract]. Cell Stem Cell 2009, 5:111-123. 10.1016/j.stem.2009.06.008, 3448781, 19570518.
126. Doi A, Park I, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009, 41:1350-1353. 10.1038/ng.471, 2958040, 19881528.
127. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LIR, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, Mckinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290. 10.1038/nature09342, 3150836, 20644535.
128. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotech 2010, 28:848-855.
129. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73. 10.1038/nature09798, 3100360, 21289626.
130. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, Yu J, Hebrok M, Hochedlinger K, Costello JF, Song JS, Ramalho-Santos M. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011, 13:541-549. 10.1038/ncb2239, 21499256.
131. Cherry AC, Daley G. Reprogramming cellular identity for regenerative medicine. Cell 2012, 148:1110-1122. 10.1016/j.cell.2012.02.031, 3354575, 22424223.
132. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305. 10.1038/nature10761, 22258608.
133. Hu Q, Friedrich AM, Johnson LV, Clegg DO. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010, 28:1981-1991. 10.1002/stem.531, 20882530.
134. Schwartz SD, Hubschman J, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720. 10.1016/S0140-6736(12)60028-2, 22281388.
135. Lamba DA, McUsic A, Hirata RK, Wang P, Russell D, Reh TA. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 2010, e8763..